CASSAVA SCIENCES INC's ticker is SAVA and the CUSIP is 14817C107. A total of 144 filers reported holding CASSAVA SCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,140,505 | -20.0% | 128,644 | +17.9% | 0.00% | -40.0% |
| Q2 2023 | $2,674,218 | -6.7% | 109,122 | -8.2% | 0.01% | 0.0% |
| Q1 2023 | $2,865,107 | +2.0% | 118,812 | +24.8% | 0.01% | -16.7% |
| Q4 2022 | $2,809,942 | +74.6% | 95,166 | +147.1% | 0.01% | +50.0% |
| Q3 2022 | $1,609,000 | +17.6% | 38,507 | -20.9% | 0.00% | +33.3% |
| Q2 2022 | $1,368,000 | -39.6% | 48,684 | -19.4% | 0.00% | -25.0% |
| Q1 2022 | $2,264,000 | +19.7% | 60,401 | +39.6% | 0.00% | 0.0% |
| Q4 2021 | $1,892,000 | -20.4% | 43,253 | +13.0% | 0.00% | -20.0% |
| Q3 2021 | $2,377,000 | +26.9% | 38,288 | +74.7% | 0.01% | +25.0% |
| Q2 2021 | $1,873,000 | -29.2% | 21,915 | -62.8% | 0.00% | -33.3% |
| Q1 2021 | $2,647,000 | +2628.9% | 58,889 | +312.6% | 0.01% | – |
| Q4 2020 | $97,000 | -57.6% | 14,274 | -28.3% | 0.00% | -100.0% |
| Q3 2020 | $229,000 | +1535.7% | 19,910 | +318.9% | 0.00% | – |
| Q2 2020 | $14,000 | +55.6% | 4,753 | +104.5% | 0.00% | – |
| Q1 2020 | $9,000 | – | 2,324 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 1,739,540 | $7,150,000 | 1.87% |
| SPHERA FUNDS MANAGEMENT LTD. | 615,000 | $2,528,000 | 0.32% |
| Worth Venture Partners, LLC | 48,535 | $200,000 | 0.12% |
| Ikarian Capital, LLC | 300,000 | $1,233,000 | 0.09% |
| Orbimed Advisors | 250,000 | $1,530,000 | 0.03% |
| Quinn Opportunity Partners LLC | 35,687 | $147,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 38,356 | $158,000 | 0.01% |
| Jefferies Group LLC | 80,000 | $329,000 | 0.00% |
| ClariVest Asset Management LLC | 33,403 | $137,000 | 0.00% |
| Renaissance Technologies | 653,759 | $2,687,000 | 0.00% |